Showing all 5 results
CentoNIPT stands at the forefront of modern prenatal care. This advanced, non-invasive prenatal test (NIPT) uses cutting-edge Next-Generation Sequencing (NGS) technology to analyze fetal DNA from a simple maternal blood draw—offering accurate insights into chromosomal conditions as early as 10 weeks into pregnancy.
Sample Type : Maternal blood
Methodology : NGS
TAT : 8 Days
Cutting-edge DNA technology, this non-invasive screening gives you answers early, so you can prepare, plan, and breathe easier.
Sample Type : Maternal blood
Methodology : PCR-single nucleotide polymorphism (SNP)-based technology
TAT : 10 Days
Sample Type : Maternal blood
Methodology : PCR-single nucleotide polymorphism (SNP)-based technology
TAT : 10 Days
Veritas NIPT Basic is a non-invasive prenatal test (NIPT) that screens for common chromosomal abnormalities, including trisomy 21 (Down syndrome), trisomy 18, and trisomy 13, using a simple maternal blood sample. It offers high accuracy, early detection from the 10th week of pregnancy, and a low false-positive rate, reducing the need for invasive procedures. The test is safe for both mother and baby, providing fast and reliable results to support informed pregnancy decisions.
Sample Type : Maternal blood
Methodology : NGS
TAT : 10 Days
Veritas NIPT Extended is a non-invasive prenatal test that screens for a broad range of chromosomal abnormalities with high accuracy. It analyzes fetal DNA from a maternal blood sample as early as the 10th week of pregnancy, detecting common conditions like Down syndrome (Trisomy 21), Edwards syndrome (Trisomy 18), and Patau syndrome (Trisomy 13), as well as sex chromosome aneuploidies and select microdeletions.
Sample Type : Maternal blood
Methodology : NGS
TAT : 10 Days